The efficacy of Xialine® in patients with Sjögren's syndrome: A single-blind, cross-over study

Clinical Oral Investigations

Volumn 12, Issue 2, 2008, Pages 165-172

  Alpöz, Esin ^a   Güneri, Pelin ^a   Önder, Gonca ^a   Çnkaya, Hülya ^a   Kabasakal, Yasemin ^a   Köse, Timur ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Artificial saliva; Dry mouth; Sj gren's disease; Xerostomia; Xialine

Indexed keywords

PLACEBO; SALIVA SUBSTITUTE; XIALINE;

ADULT; AGED; ARTICLE; CHEILITIS; CLASSIFICATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRINKING; DRUG EFFECT; FOLLOW UP; HUMAN; MASTICATION; MIDDLE AGED; MOUTH MUCOSA; PATIENT SATISFACTION; PHYSIOLOGY; SALIVA; SECRETION; SINGLE BLIND PROCEDURE; SJOEGREN SYNDROME; SPEECH; SWALLOWING; TASTE DISORDER; TONGUE DISEASE; TREATMENT OUTCOME; XEROSTOMIA;

ADULT; AGED; CHEILITIS; CROSS-OVER STUDIES; DEGLUTITION; DRINKING; FOLLOW-UP STUDIES; HUMANS; MASTICATION; MIDDLE AGED; MOUTH MUCOSA; PATIENT SATISFACTION; PLACEBOS; SALIVA; SALIVA, ARTIFICIAL; SECRETORY RATE; SINGLE-BLIND METHOD; SJOGREN'S SYNDROME; SPEECH; TASTE DISORDERS; TONGUE DISEASES; TREATMENT OUTCOME; XEROSTOMIA;

EID: 43049136220     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-007-0159-3     Document Type: Article

References (41)

1. Akhtar-Danesh N (2001) A review for statistical methods for analysing pain measurements. Eur J Pain 5:457-463
2. Alves M, Motta CF, Messina W (2004) Saliva substitute in xerostomic patients with primary Sjögren's syndrome: A single-blind trial. Quintessence Int 35:392-396
3. Amerongen AVN, Veerman ECI (2003) Current therapies for xerostomia and salivary with cancer therapies. Support Care Cancer 11:226-231
4. Bainbridge D, Martin JE, Cheng DC (2006) Patient-controlled versus nurse-controlled analgesia after cardiac surgery - A meta-analysis. Can J Anaesth 53:492-499
5. Bergdahl M (2000) Salivary flow and oral complaints in adult dental patients. Community Dent Oral Epidemiol 28:59-66
6. Caraceni A, Brunelli C, Martini C, Zecca E, De Conno F (2005) Cancer pain assessment in clinical trials. A review of the literature (1999-2002). J Pain Symptom Manage 29:507-519
7. Chisholm DM, Mason D (1968) Labial salivary gland biopsy in Sjügren's disease. J Clin Path 21:656-660
8. Christersson CE, Lindh L, Arnebrandt T (2000) Film forming properties and viscosities of saliva substitutes and human whole saliva. Eur J Oral Sci 108:418-425
9. Çankaya H, Kabasakal Y (2001) Comparison of subjective and objective oral findings in patients with Sjögren's Syndrome. Balk J Stom 5:115-117
10. de Hertogh WJ, Vaes PH, Vijverman V, de Cordt A, Duquet W (2006) The clinical examination of neck pain patients: The validity of a group of tests. Man Ther (in press), PMID Number 16769236
11. Fife RS, Chase WF, Dore RK, Wiesenhutter CR, Lockhart PB, Tindall E, Suen JY (2002) Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome. Arch Intern Med 162:1293-1300
12. Fox PC (2004) Salivary enhancement therapies. Caries Res 38:241-246
13. Freeman K, Smyth C, Dallam L, Jackson B (2001) Pain measurement scales: a comparison of the visual analogue and faces rating scales in measuring pressure ulcer pain. J Wound Ostomy Continence Nurs 28:290-296
14. Gould D, Kelly D, Goldstone L, Gammon J (2001) Examining the validity of pressure ulcer risk assessment scales: Developing and using illustrated patient simulations to collect the data. J Clin Nurs 10:97-706
15. Guest S, Essick G, Young M, Lee A, Phillips N, McGlone F (2006) Oral hydration, parotid salivation and the perceived pleasantness of small water volumes. Physiol Behav 89:724-734
16. http://www.answers.com/topic/xanthan-gum, 2007
17. http://www.lsbu.ac.uk/water/hyxan.html, 2007
18. Jamison RN, Raymond SA, Slawsby EA, McHugo GJ, Baird JC (2006) Pain assessment in patients with low back pain: Comparison of weekly recall and momentary electronic data. J Pain 7:192-199
19. Jellema AP, Langendijk H, Bergenhenegouwen L, van der Reijden TJK, Leemans R, Smeele L, Slotman BJ (2001) The efficiacy of Xialine in patients with xerostomia resulting from radiotherapy for head and neck cancer: A pilot study. Radiother Oncol 59:157-160
20. Jensen SB, Pedersen AM, Reibel J, Nauntofte B (2003) Xerostomia and hypofunction of the salivary glands in cancer theraphy. Support Care Cancer 11:207-225
21. Jorkjend L, Johansson A, Johansson A-K, Bergenholtz A (2004) Resting and stimulated whole salivary flow rates in Sjögren's syndrome patients over time: A diagnostic aid for subsidized dental care? Acta Odontol Scand 62:264-268
22. Kahn ST, Johnstone PA (2005) Management of xerostomia related to radiotherapy for head and neck cancer. Oncology (Williston Park) 19:1827-1839
23. Khurshudian AV (2003) A pilot study to test the efficacy of oral administration of interferon lozenges to patients with Sjügren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 95:38-44
24. Levine MJ (1993) Development of artificial salivas. Crit Rev Oral Biol Med 4:279-286
25. Mignogna MD, Fedele S, Russo LL, Muzio L, Wolf A (2005) Sjögren's syndrome: The diagnostic potential of early oral manifestations preceding hyposalivation/xerostomia. J Oral Pathol Med 34:1-6
26. -3 concentrations of linseed-based saliva substitutes on enamel in vitro. J Oral Rehab 33:760-766
27. Narhi TM, Meurman JK, Ainamo A (1999) Xerostomia and hyposalivation. Causes, consequences and treatment in the elderly. Drugs Aging 15:103-116
28. Navazesh M, Christensen C, Brightman V (1992) Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res 71:1363-1369
29. Park MS, Chung JW, Kim YK, Chung SC, Kho HS (2007) Viscosity and wettability of animal mucin solutions and human saliva. Oral Diseases 13:181-186
30. Porter SR, Scully C, Hegarty AM (2004) An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 97:28-46
31. Preetha A, Banerjee R (2005) Comparison of artificial saliva substitutes. Trends Biomater Artif Organs 18:178-186
32. Puy LC (2006) The role of saliva in maintaining oral health and as an aid to diagnosis. Med Oral Patol Cir Bucal 11:449-455
33. Reijden WA, Vissink A, Veerman EC, Amerongen AVN (1999) Treatment of oral dryness related complaints (xerostomia) in Sjögren's syndrome. Ann Rheum Dis 58:465-473
34. Samarawickrama DYD (2002) Saliva substitutes: How effective and safe are they? Guest Editorial. Oral Dis 8:177-179
35. Saunders BD, Trapp RG (1994) Basic and clinical biostatistics, 2nd edn. Prentice-Hall, International Inc, pp 138-139
36. Shahdad SA (2005) A double-blind, cross-over study of Biotene Oralbalance and Bioxtra systems as salivary substitutes in patients with post-radiotheraphy xerostomia. Eur J Cancer Care 14:319-326
37. Ship JA (2002) Diagnosing, managing, and preventing salivary gland disorders. Oral Dis 8:77-89
38. Smith G, Smith AJ, Shaw L, Shaw MJ (2001) Artificial saliva substitutes and mineral dissolution. J Oral Rehab 28:728-731
39. Sokka T (2005) Assessment of pain in rheumatic diseases. Clin Exp Rheumatol 23(5 Suppl 39):77-84
40. Wu AJ (2003) The oral component of Sjogren's syndrome: Pass the scalpel and check the water. Curr Rheumatol Rep 5:304-310
41. Zanoli G (2005) Outcome assessment in lumbar spine surgery. Acta Orthop Suppl 76:5-47